Position in VRTX
as of Mar 31, 2026
· filed Apr 10, 2026
Position Value
$11,694,436
-$1,204,562 QoQ
Shares Held
26,189
-8.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026OP Asset Management Ltd holds $58,432,294 across 25 Biotechnology names. VRTX ranks #1 (20.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
26,189 | $11,694,436 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,139 | $10,924,356 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,477 | $7,767,834 | |
| 4 | INSM |
INSMED Inc
|
22,222 | $3,633,741 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
33,633 | $3,270,809 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
56,060 | $3,166,829 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
609,112 | $2,405,992 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
33,602 | $2,289,304 |
All Filings in VRTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,694,436 | 26,189 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $12,898,998 | 28,452 | Shares | Sole | 2026-04-21 | |
| 2025-09-30 | $11,078,712 | 28,288 | Shares | Sole | 2026-04-20 | |
| 2025-06-30 | $12,366,320 | 27,777 | Shares | Sole | 2026-04-20 | |
| 2025-03-31 | $13,298,612 | 27,430 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||